Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc. is a biotechnology company focused on developing innovative cell therapies for cancer treatment. The company aims to harness the power of the immune system to create effective therapies that can overcome the limitations of traditional cancer treatments. Lyell's proprietary technology platform is designed to enhance the persistence and functionality of T cells, enabling them to better target and eliminate cancer cells. With a strong emphasis on research and development, Lyell is committed to advancing its pipeline of therapies to improve patient outcomes in oncology.